Cargando…
Detection of drug-sensitizing EGFR exon 19 deletion mutations in salivary gland carcinoma
Activating mutations within the epidermal growth factor receptor (EGFR) identify lung adenocarcinoma patients with improved clinical responses to tyrosine kinase inhibitors gefitinib and erlotinib. By screening salivary gland carcinoma, two drug-sensitizing EGFR exon 19 delE746-A750 mutations were i...
Autores principales: | Dahse, R, Kosmehl, H |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2453031/ https://www.ncbi.nlm.nih.gov/pubmed/18542074 http://dx.doi.org/10.1038/sj.bjc.6604430 |
Ejemplares similares
-
No Incidence of BRAF Mutations in Salivary Gland Carcinomas—Implications for Anti-EGFR Therapies
por: Dahse, Regine, et al.
Publicado: (2009) -
Epidermal growth factor receptor kinase domain mutations are rare in salivary gland carcinomas
por: Dahse, R, et al.
Publicado: (2009) -
Detection of a novel mutation in exon 20 of the BRCA1 gene
por: Chakraborty, Abhijit, et al.
Publicado: (2013) -
Discovery of new salivary gland – A substantial histological analysis
por: N.B., Pushpa, et al.
Publicado: (2021) -
Detection of Somatic Mutation in Exon 12 of DNA Polymerase β in Ovarian Cancer Tissue Samples
por: Khanra, Kalyani, et al.
Publicado: (2018)